Cloxacillin and drug combination for prevention of postoperative infections in patients undergoing head and neck reconstructive surgery

3 1 1 1

What is this study about?

The study focuses on the treatment and prevention of post operative infections, which are infections that can occur after surgery in the head and neck area. The main goal is to find out how much of the antibiotics reach the blood and the surgical site when they are given during the operation.

Participants will receive one of several commonly used antibiotics: amoxicillin combined with clavulanic acid taken by mouth, cloxacillin given through a vein, cefuroxime also given intravenously, and dicloxacillin taken orally. These medicines are standard treatments that doctors use to stop bacteria from growing after surgery.

During the study, small samples of blood (the liquid part of blood called plasma) and fluid from the surgical area will be collected at several time points after the antibiotic is given. The fluid is obtained with a tiny tube that gently draws out fluid from the tissue, a technique called microdialysis, which allows researchers to measure the amount of drug present over time. The collected samples are then analyzed to see how long the drug levels stay above the amount needed to stop bacterial growth.

1 enrollment and baseline assessment

after joining the study you will meet the study staff who will confirm that you meet the inclusion criteria and explain the purpose of the trial.

baseline measurements will be taken, including a blood sample to assess your health before any medication is given.

2 microdialysis catheter placement and initial sampling

a small catheter will be inserted into the surgical site to collect fluid from the tissue; this technique is called microdialysis and allows measurement of antibiotic levels directly in the tissue.

initial tissue fluid and additional blood sample will be collected before any antibiotic is administered.

3 start of oral antibiotic regimen

you will take an oral tablet that contains amoxicillin 1500 mg combined with clavulanic acid 375 mg.

the tablet is taken by mouth as directed by the study schedule, typically at regular intervals (for example every 8 hours) for the duration defined by the study protocol.

4 intravenous antibiotic administration

you will receive cloxacillin 4 g given intravenously, cefuroxime 4.5 g given intravenously, and dicloxacillin 4 g given intravenously.

each infusion is given according to the study schedule, usually as a single dose or repeated doses as specified by the protocol, for the period required by the study.

5 repeated blood and tissue sampling

throughout the treatment period additional blood samples and tissue fluid collected by the microdialysis catheter will be taken at predefined times.

these samples are used to measure the concentration of the antibiotics in your blood and in the tissue.

6 final assessment and catheter removal

at the end of the treatment period a final set of samples will be collected.

the microdialysis catheter will be removed, and a concluding health assessment will be performed to complete your participation in the trial.

Who Can Join the Study?

  • Signed informed consent – you agree in writing to take part after understanding what the study involves.
  • Having either a post‑operative neck infection (an infection that occurs after neck surgery) or a planned surgery that uses an inferior turbinate flap (IFT flap) – a piece of tissue taken from inside the nose to help rebuild another area.
  • Being at least 18 years old – you must be an adult.
  • Being a man or a woman – the study accepts participants of any gender.

Who Cannot Join the Study?

  • Having a known allergy or strong reaction (hypersensitivity) to any of the study antibiotics (the medicines called cefuroxime, cloxacillin, dicloxacillin, or amoxicillin/clavulanic acid).
  • Being currently pregnant or planning to become pregnant.
  • Having an eGFR (a test that shows how well the kidneys work) lower than 30 ml/min/1.73 m², which means the kidneys are not functioning well enough.

Where you can join this trial?

Verified and Recommended Sites

No sites found in this category

Verified Sites

No sites found in this category

Other Sites

Site Name City Country Status
Rzkzmn Mvzsdobpuve Aarhus Denmark

Want to learn more about this study or check if you can participate? Contact us.

Trial status

Country Status Recruitment Start
Denmark Denmark
Not yet recruiting
01.08.2026

Trial locations

Clavulanic acid is a medication that blocks enzymes made by some bacteria that can destroy antibiotics. In this study it is given by mouth to see how much of the drug reaches the blood and the tissue in the head and neck area.

Amoxicillin is a commonly used antibiotic that kills many types of bacteria. In the trial it is taken orally, and researchers measure how well it moves from the bloodstream into the tissues after surgery.

Cloxacillin is an antibiotic given through a vein (intravenously) that works against certain bacteria that cause infections. The study looks at how much of this drug enters the blood and the surgical tissue.

Cefuroxime is a broad‑spectrum antibiotic given by IV that treats a wide range of bacterial infections. The trial checks its levels in plasma and in the head‑neck tissue after it is administered.

Dicloxacillin is an oral antibiotic that targets bacteria often found in skin and soft‑tissue infections. In this research it is taken by mouth, and its penetration into tissue and blood is measured.

Surgical site infection – A surgical site infection is an infection that occurs at the part of the body where a surgery was performed. It can involve the skin, tissue under the skin, or deeper structures such as organs or spaces opened during the operation. The infection usually appears within a few days after surgery and may start with redness, warmth, pain, and swelling at the incision. If the infection spreads, it can lead to the formation of pus, breakdown of tissue, and may extend to surrounding areas. In some cases, the infection can become systemic, causing fever and a general feeling of being unwell.

Trial ID:
2026-526995-22-00
Protocol code:
310816
Trial Phase:
Therapeutic confirmatory (Phase III)

Other Trials to Consider

  • A Study of Felzartamab for Kidney Transplant Patients with Late Isolated Microvascular Inflammation

    Recruiting

    2 1 1
    Investigated Diseases:
    Austria Czechia France Germany Spain
  • Study of Baricitinib in Children Aged 1 to 17 Hospitalized with COVID-19

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Spain